日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Vascular graph network for ovarian lesion classification using optical-resolution photoacoustic microscopy

利用光学分辨率光声显微镜构建卵巢病变分类的血管图网络

Lin, Yixiao; Wang, Lukai; Hagemann, Ian S; Kuroki, Lindsay M; Sanders, Brooke E; Hagemann, Andrea R; Siegel, Cary; Powell, Matthew A; Zhu, Quing

Pembrolizumab plus chemotherapy in advanced or recurrent endometrial cancer: overall survival and exploratory analyses of the NRG GY018 phase 3 randomized trial

帕博利珠单抗联合化疗治疗晚期或复发性子宫内膜癌:NRG GY018 3期随机试验的总生存期和探索性分析

Eskander, Ramez N; Sill, Michael W; Beffa, Lindsey; Moore, Richard G; Hope, Joanie M; Musa, Fernanda B; Mannel, Robert S; Shahin, Mark S; Cantuaria, Guilherme H; Girda, Eugenia; Lokich, Elizabeth; Kavecansky, Juraj; Leath, Charles A 3rd; Gien, Lilian T; Hinchcliff, Emily M; Lele, Shashikant B; Landrum, Lisa M; Backes, Floor; O'Cearbhaill, Roisin E; Baghdadi, Tareq Al; Hill, Emily K; Thaker, Premal H; John, Veena S; Welch, Stephen; Fader, Amanda N; Powell, Matthew A; Aghajanian, Carol

Long-Term Follow-Up and Overall Survival in NRG258, a Randomized Phase III Trial of Chemoradiation Versus Chemotherapy for Locally Advanced Endometrial Carcinoma

NRG258 是一项随机 III 期试验,比较放化疗与单纯化疗治疗局部晚期子宫内膜癌的疗效,本研究的长期随访和总生存期如下:

Matei, Daniela E; Enserro, Danielle M; Randall, Marcus E; Mutch, David; Small, William; DiSilvestro, Paul A; Spirtos, Nick M; O'Malley, David M; Cantuaria, Guilherme H; Michelin, David; Waggoner, Steven; Shahin, Mark; Guntupalli, Saketh; Lara, Olivia; Ueland, Frederick R; Warshal, David; Bonebrake, Albert; Tewari, Krishnansu S; Tan, Annie; Powell, Matthew A; Walker, Joan L; Santin, Alessandro D; Kim, Jong Hyeok; Miller, David S

Multiomic Characterization of Pre- and Post-Neoadjuvant Chemotherapy-Treated Ovarian Cancer Reveals Mediators of Tumorigenesis and Chemotherapy Response

新辅助化疗前后卵巢癌的多组学特征分析揭示了肿瘤发生和化疗反应的介质

Valentine, Mark C; Mullen, Mary M; Kotnik, Emilee N; Powell, Matthew A; Thaker, Premal H; McCourt, Carolyn K; Kuroki, Lindsay M; Hagemann, Andrea R; Arend, Rebecca C; Holehouse, Alex S; Mitra, Robi; Mutch, David G; Fuh, Katherine C

A plain language summary publication of patients' survival with endometrial cancer treated with dostarlimab plus carboplatin-paclitaxel

一份用通俗易懂的语言总结了接受多斯他利单抗联合卡铂-紫杉醇治疗的子宫内膜癌患者的生存情况的报告。

Powell, Matthew A; Bjørge, Line; Willmott, Lyndsay; Novák, Zoltán; Black, Destin; Gilbert, Lucy; Sharma, Sudarshan; Valabrega, Giorgio; Landrum, Lisa M; Gropp-Meier, Martina; Stuckey, Ashley; Boere, Ingrid; Gold, Michael A; Segev, Yakir; Gill, Sarah E; Gennigens, Christine; Sebastianelli, Alexandra; Shahin, Mark S; Pothuri, Bhavana; Monk, Bradley J; Buscema, Joseph; Coleman, Robert L; Slomovitz, Brian M; Ring, Kari L; Herzog, Thomas J; Balas, Morad Marco; Grimshaw, Matthew; Stevens, Shadi; Lai, Dominic W; McCourt, Carolyn; Mirza, Mansoor Raza

Prospective assessment of prognostic significance of malignant peritoneal cytology in endometrial cancer: An NRG Oncology / Gynecologic Oncology Group study on GOG-210 protocol

前瞻性评估腹膜恶性细胞学在子宫内膜癌预后中的意义:一项基于 GOG-210 方案的 NRG 肿瘤/妇科肿瘤协作组研究

Matsuo, Koji; Enserro, Danielle M; Wright, Jason D; Roman, Lynda D; Powell, Matthew A; Miller, David S; Nagel, Christa I; Thaker, Premal H; Mannel, Robert S; Stuckey, Ashley R; Guntupalli, Saketh R; Sukumvanich, Paniti; Geller, Melissa A; Vargas, Roberto; Konecny, Gottfried E; Warshal, David P; Tewari, Krishnansu S; Spirtos, Nick M; Pothuri, Bhavana; Creasman, William T; Mutch, David G

A Plain Language Summary of "Dostarlimab for primary advanced or recurrent endometrial cancer"

“多斯利单抗治疗原发性晚期或复发性子宫内膜癌”的简明语言摘要

Mirza, Mansoor R; Chase, Dana M; Slomovitz, Brian M; Christensen, René dePont; Novák, Zoltán; Black, Destin; Gilbert, Lucy; Sharma, Sudarshan; Valabrega, Giorgio; Landrum, Lisa M; Hanker, Lars C; Stuckey, Ashley; Boere, Ingrid; Gold, Michael A; Auranen, Annika; Pothuri, Bhavana; Cibula, David; McCourt, Carolyn; Raspagliesi, Francesco; Shahin, Mark S; Gill, Sarah E; Monk, Bradley J; Buscema, Joseph; Herzog, Thomas J; Copeland, Larry J; Tian, Min; He, Zangdong; Stevens, Shadi; Zografos, Eleftherios; Coleman, Robert L; Powell, Matthew A

Targeting RAD52 overcomes PARP inhibitor resistance in preclinical Brca2-deficient ovarian cancer model.

在临床前 Brca2 缺陷型卵巢癌模型中,靶向 RAD52 可克服 PARP 抑制剂耐药性。

Ota Yukihide, Gupta Vijayalaxmi, Fashemi Bisiayo E, Akande Moreniola, Babu Preedia, Thuthika Prasanth, Elizagaray Maia L, Sun Lulu, Sanders Brooke, Kuroki Lindsay M, McCourt Carolyn K, Hagemann Andrea R, Hagemann Ian S, Thaker Premal H, Mutch David G, Powell Matthew A, Hyrc Krzysztof, Verma Priyanka, Krais John, Bitler Benjamin G, Mullen Mary, Khabele Dineo

Accuracy of surveillance serum squamous cell carcinoma antigen for cervical cancer recurrence after definitive chemoradiation

血清鳞状细胞癌抗原监测在宫颈癌根治性放化疗后复发预测中的准确性

Shi, Victoria; Grover, Surbhi; Huang, Yi; Thaker, Premal H; Kuroki, Lindsay M; Powell, Matthew A; Mutch, David G; Contreras, Jessika A; Schwarz, Julie K; Grigsby, Perry W; Markovina, Stephanie

Safety of dostarlimab in combination with chemotherapy in patients with primary advanced or recurrent endometrial cancer in a phase III, randomized, placebo-controlled trial (ENGOT-EN6-NSGO/GOG-3031/RUBY)

在 III 期随机、安慰剂对照试验中,评估了 dostarlimab 与化疗联合治疗原发性晚期或复发性子宫内膜癌患者的安全性 (ENGOT-EN6-NSGO/GOG-3031/RUBY)

Auranen, Annika; Powell, Matthew A; Sukhin, Vladyslav; Landrum, Lisa M; Ronzino, Graziana; Buscema, Joseph; Bauerschlag, Dirk; Lalisang, Roy; Bender, David; Gilbert, Lucy; Armstrong, Amy; Safra, Tamar; Nevadunsky, Nicole; Sebastianelli, Alexandra; Slomovitz, Brian; Ring, Kari; Coleman, Robert; Podzielinski, Iwona; Stuckey, Ashley; Teneriello, Michael; Gill, Sarah; Pothuri, Bhavana; Willmott, Lyndsay; Sharma, Sudarshan; Dabrowski, Christine; Antony, Grace; Stevens, Shadi; Mirza, Mansoor Raza; Fleming, Evelyn